VPS37C
gene geneOn this page
Also known as FLJ20847
Summary
VPS37C (VPS37C subunit of ESCRT-I, HGNC:26097) is a protein-coding gene on chromosome 11q12.2, encoding Vacuolar protein sorting-associated protein 37C (A5D8V6). Component of the ESCRT-I complex, a regulator of vesicular trafficking process.
VPS37C is a subunit of ESCRT-I (endosomal sorting complex required for transport I), a complex in the class E vacuolar protein sorting (VPS) pathway required for sorting ubiquitinated transmembrane proteins into internal vesicles of multivesicular bodies (Eastman et al., 2005 [PubMed 15509564]).
Source: NCBI Gene 55048 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 76 total
- MANE Select transcript:
NM_017966
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26097 |
| Approved symbol | VPS37C |
| Name | VPS37C subunit of ESCRT-I |
| Location | 11q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20847 |
| Ensembl gene | ENSG00000167987 |
| Ensembl biotype | protein_coding |
| OMIM | 610038 |
| Entrez | 55048 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 15 protein_coding, 2 retained_intron
ENST00000301765, ENST00000535818, ENST00000536000, ENST00000538036, ENST00000865209, ENST00000865210, ENST00000865211, ENST00000865212, ENST00000865213, ENST00000865214, ENST00000932806, ENST00000932807, ENST00000932808, ENST00000932809, ENST00000932810, ENST00000932811, ENST00000969167
RefSeq mRNA: 1 — MANE Select: NM_017966
NM_017966
CCDS: CCDS31573
Canonical transcript exons
ENST00000301765 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001119066 | 61133255 | 61133337 |
| ENSE00001248522 | 61130257 | 61132539 |
| ENSE00002323686 | 61161391 | 61161426 |
| ENSE00003510659 | 61134036 | 61134207 |
| ENSE00003594793 | 61138737 | 61138835 |
Expression profiles
Bgee: expression breadth ubiquitous, 288 present calls, max score 98.27.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.8642 / max 297.4962, expressed in 1799 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 119955 | 5.9401 | 1726 |
| 119954 | 5.8307 | 1722 |
| 119953 | 0.0934 | 24 |
Top tissues by expression
289 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 98.27 | gold quality |
| amniotic fluid | UBERON:0000173 | 97.81 | gold quality |
| endothelial cell | CL:0000115 | 97.51 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 97.21 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 96.95 | gold quality |
| oocyte | CL:0000023 | 96.54 | gold quality |
| visceral pleura | UBERON:0002401 | 96.54 | gold quality |
| type B pancreatic cell | CL:0000169 | 96.47 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 96.13 | gold quality |
| squamous epithelium | UBERON:0006914 | 95.77 | gold quality |
| parotid gland | UBERON:0001831 | 95.40 | gold quality |
| eye | UBERON:0000970 | 95.38 | gold quality |
| parietal pleura | UBERON:0002400 | 95.04 | gold quality |
| pleura | UBERON:0000977 | 94.96 | gold quality |
| cardia of stomach | UBERON:0001162 | 94.87 | gold quality |
| sperm | CL:0000019 | 94.67 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 94.65 | gold quality |
| gingival epithelium | UBERON:0001949 | 94.44 | gold quality |
| pylorus | UBERON:0001166 | 94.42 | gold quality |
| skin of hip | UBERON:0001554 | 94.40 | gold quality |
| male germ cell | CL:0000015 | 94.26 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 94.26 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 94.05 | gold quality |
| bronchial epithelial cell | CL:0002328 | 93.94 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 93.71 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 93.67 | gold quality |
| upper leg skin | UBERON:0004262 | 93.62 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 93.61 | gold quality |
| bronchus | UBERON:0002185 | 93.58 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 93.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
92 targeting VPS37C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-767-5P | 99.95 | 70.85 | 993 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-498-3P | 99.91 | 71.27 | 1114 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4756-5P | 99.84 | 64.98 | 1809 |
| HSA-MIR-6715A-3P | 99.83 | 68.05 | 1473 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
Literature-anchored findings (GeneRIF, showing 3)
- VPS37C as a functional component of mammalian endosomal sorting complex required for transport-I (PMID:15509564)
- VPS37B and appeared to interact with ALG-2 in a stronger manner than TSG101 does (PMID:23924735)
- VPS37C facilitates erythroid differentiation by promoting EKLF stability. (PMID:37307706)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | vps37c | ENSDARG00000031836 |
| mus_musculus | Vps37c | ENSMUSG00000048832 |
| rattus_norvegicus | Vps37c | ENSRNOG00000046439 |
| drosophila_melanogaster | Vps37B | FBGN0037299 |
Paralogs (3): VPS37B (ENSG00000139722), VPS37A (ENSG00000155975), VPS37D (ENSG00000176428)
Protein
Protein identifiers
Vacuolar protein sorting-associated protein 37C — A5D8V6 (reviewed: A5D8V6)
Alternative names: ESCRT-I complex subunit VPS37C
All UniProt accessions (2): A5D8V6, F5H4Q5
UniProt curated annotations — full annotation on UniProt →
Function. Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies. May be involved in cell growth and differentiation.
Subunit / interactions. Component of the ESCRT-I complex (endosomal sorting complex required for transport I) which consists of TSG101, VPS28, a VPS37 protein (VPS37A to -D) and MVB12A or MVB12B in a 1:1:1:1 stoichiometry. Interacts with TSG101, VPS28, MVB12A and MVB12B. Component of the ESCRT-I complex (endosomal sorting complex required for transport I) which consists of TSG101, VPS28, a VPS37 protein (VPS37A to -D) and UBAP1 in a 1:1:1:1 stoichiometry. Interacts with HGS and STAM2. Interacts with CEP55.
Subcellular location. Late endosome membrane.
Post-translational modifications. Phosphorylated by TBK1.
Similarity. Belongs to the VPS37 family.
RefSeq proteins (1): NP_060436* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009851 | Mod_r | Domain |
| IPR029012 | Helix_hairpin_bin_sf | Homologous_superfamily |
| IPR037202 | ESCRT_assembly_dom | Homologous_superfamily |
Pfam: PF07200
UniProt features (10 total): compositionally biased region 4, sequence variant 2, chain 1, domain 1, region of interest 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A5D8V6-F1 | 68.94 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 29
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-162588 | Budding and maturation of HIV virion |
| R-HSA-174490 | Membrane binding and targetting of GAG proteins |
| R-HSA-917729 | Endosomal Sorting Complex Required For Transport (ESCRT) |
| R-HSA-9610379 | HCMV Late Events |
| R-HSA-9615710 | Late endosomal microautophagy |
MSigDB gene sets: 203 (showing top):
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT, GOBP_ENDOSOME_ORGANIZATION, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_VESICLE_ORGANIZATION, GOBP_PROTEIN_TARGETING, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_VACUOLAR_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_MACROAUTOPHAGY, GTGCCTT_MIR506, GOBP_PROTEIN_TARGETING_TO_MEMBRANE, REACTOME_HIV_INFECTION, GOBP_PROTEIN_LOCALIZATION_TO_VACUOLE
GO Biological Process (9): protein targeting to membrane (GO:0006612), protein targeting to vacuole (GO:0006623), macroautophagy (GO:0016236), multivesicular body assembly (GO:0036258), viral budding via host ESCRT complex (GO:0039702), ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162), protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328), membrane fission (GO:0090148), protein transport (GO:0015031)
GO Molecular Function (2): calcium-dependent protein binding (GO:0048306), protein binding (GO:0005515)
GO Cellular Component (9): ESCRT I complex (GO:0000813), nucleoplasm (GO:0005654), Golgi apparatus (GO:0005794), cilium (GO:0005929), endosome membrane (GO:0010008), late endosome membrane (GO:0031902), extracellular exosome (GO:0070062), endosome (GO:0005768), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Late Phase of HIV Life Cycle | 1 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | 1 |
| Membrane Trafficking | 1 |
| HCMV Infection | 1 |
| Autophagy | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein targeting | 2 |
| intracellular protein transport | 2 |
| protein localization to vacuole | 2 |
| establishment of protein localization to vacuole | 2 |
| endosome membrane | 2 |
| cellular anatomical structure | 2 |
| endomembrane system | 2 |
| establishment of protein localization to membrane | 1 |
| vacuolar transport | 1 |
| autophagosome assembly | 1 |
| autophagy | 1 |
| multivesicular body organization | 1 |
| organelle assembly | 1 |
| viral budding | 1 |
| ubiquitin-dependent protein catabolic process | 1 |
| protein catabolic process in the vacuole | 1 |
| multivesicular body sorting pathway | 1 |
| late endosome to vacuole transport via multivesicular body sorting pathway | 1 |
| ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1 |
| membrane organization | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| calcium ion binding | 1 |
| protein binding | 1 |
| binding | 1 |
| ESCRT complex | 1 |
| membrane protein complex | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| endosome | 1 |
| cytoplasmic vesicle membrane | 1 |
| bounding membrane of organelle | 1 |
| late endosome | 1 |
| extracellular vesicle | 1 |
| cytoplasmic vesicle | 1 |
Protein interactions and networks
STRING
714 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| VPS37C | VPS28 | Q9UK41 | 969 |
| VPS37C | TSG101 | Q99816 | 921 |
| VPS37C | VPS4A | Q9UN37 | 839 |
| VPS37C | VPS36 | Q86VN1 | 740 |
| VPS37C | MVB12A | Q96EY5 | 728 |
| VPS37C | SNF8 | Q96H20 | 696 |
| VPS37C | UBAP1 | Q9NZ09 | 664 |
| VPS37C | MVB12B | Q9H7P6 | 646 |
| VPS37C | VPS25 | Q9BRG1 | 584 |
| VPS37C | ABCC3 | O15438 | 583 |
| VPS37C | CHMP2A | O43633 | 567 |
| VPS37C | VPS4B | O75351 | 560 |
| VPS37C | CHMP4C | Q96CF2 | 534 |
| VPS37C | CHMP6 | Q96FZ7 | 525 |
| VPS37C | TOM1L1 | O75674 | 462 |
IntAct
385 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP55 | VPS37C | psi-mi:“MI:0915”(physical association) | 0.800 |
| VPS37C | CEP55 | psi-mi:“MI:0915”(physical association) | 0.800 |
| VPS37C | XIAP | psi-mi:“MI:0915”(physical association) | 0.780 |
| TSG101 | VPS37C | psi-mi:“MI:0915”(physical association) | 0.780 |
| XIAP | VPS37C | psi-mi:“MI:0915”(physical association) | 0.780 |
| VPS37C | TSG101 | psi-mi:“MI:0915”(physical association) | 0.780 |
| VPS37C | WWP2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| VPS37C | SORBS3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PDCD6 | VPS37C | psi-mi:“MI:0915”(physical association) | 0.720 |
| VPS37C | STAM2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| VPS37C | DAZAP2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| VPS37C | C1orf94 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MAPK1IP1L | VPS37C | psi-mi:“MI:0915”(physical association) | 0.720 |
| TFG | VPS37C | psi-mi:“MI:0915”(physical association) | 0.720 |
| STAM2 | VPS37C | psi-mi:“MI:0915”(physical association) | 0.720 |
| VPS37C | MAPK1IP1L | psi-mi:“MI:0915”(physical association) | 0.720 |
| VPS37C | PDCD6 | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (172): VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid), VPS37C (Two-hybrid)
ESM2 similar proteins: A0JPN4, A2A9T0, A5D8V6, A6ND36, A6QQJ8, A7MCY6, E9Q2Z1, O14529, O54714, O70260, O88902, P70298, P98175, Q07912, Q0IIJ3, Q13227, Q13625, Q148V8, Q15025, Q15942, Q3SZL6, Q3U564, Q3UIL6, Q499E4, Q5BJU7, Q5D1E7, Q5D1E8, Q5NVG8, Q5R9T2, Q5RBV9, Q5U2X5, Q5XIA0, Q61140, Q62415, Q62523, Q63767, Q6DG50, Q6IQ23, Q810I0, Q8CG79
Diamond homologs: A5D8V6, Q5R9T2, Q810I0, Q86XT2, Q8R0J7, Q8R105, Q9H9H4, Q9SCP9, Q8NEZ2, Q3EBL9
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TBK1 | “down-regulates activity” | VPS37C | phosphorylation |
Disease & clinical
Clinical variants and AI predictions
ClinVar
76 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 63 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1536 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:61132424:T:TA | donor_gain | 1.0000 |
| 11:61132536:TGGC:T | acceptor_gain | 1.0000 |
| 11:61132538:GCCTG:G | acceptor_loss | 1.0000 |
| 11:61132539:CCTGG:C | acceptor_loss | 1.0000 |
| 11:61132540:C:CC | acceptor_gain | 1.0000 |
| 11:61132540:CTGGA:C | acceptor_loss | 1.0000 |
| 11:61132541:T:A | acceptor_loss | 1.0000 |
| 11:61132549:A:C | acceptor_gain | 1.0000 |
| 11:61134032:CTACC:C | donor_loss | 1.0000 |
| 11:61134033:TA:T | donor_loss | 1.0000 |
| 11:61134034:A:AC | donor_gain | 1.0000 |
| 11:61134034:AC:A | donor_gain | 1.0000 |
| 11:61134035:C:CC | donor_gain | 1.0000 |
| 11:61134035:CC:C | donor_gain | 1.0000 |
| 11:61134035:CCCAG:C | donor_gain | 1.0000 |
| 11:61134039:G:C | donor_gain | 1.0000 |
| 11:61134075:T:TA | donor_gain | 1.0000 |
| 11:61134205:GACC:G | acceptor_loss | 1.0000 |
| 11:61134208:C:CC | acceptor_gain | 1.0000 |
| 11:61132535:ATGGC:A | acceptor_gain | 0.9900 |
| 11:61132537:GGC:G | acceptor_gain | 0.9900 |
| 11:61132538:GC:G | acceptor_gain | 0.9900 |
| 11:61132539:CC:C | acceptor_gain | 0.9900 |
| 11:61132548:C:CT | acceptor_gain | 0.9900 |
| 11:61133249:TCTCA:T | donor_loss | 0.9900 |
| 11:61133250:CTCA:C | donor_loss | 0.9900 |
| 11:61133251:TCAC:T | donor_loss | 0.9900 |
| 11:61133252:CACC:C | donor_loss | 0.9900 |
| 11:61133253:A:C | donor_loss | 0.9900 |
| 11:61133254:CCTC:C | donor_loss | 0.9900 |
AlphaMissense
2244 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:61132492:G:C | F132L | 0.999 |
| 11:61132492:G:T | F132L | 0.999 |
| 11:61132494:A:G | F132L | 0.999 |
| 11:61134161:C:G | R47P | 0.999 |
| 11:61132493:A:G | F132S | 0.998 |
| 11:61132523:A:G | F122S | 0.998 |
| 11:61133260:A:G | S115P | 0.998 |
| 11:61134080:A:G | L74P | 0.998 |
| 11:61134177:C:G | A42P | 0.998 |
| 11:61132448:C:G | R147P | 0.997 |
| 11:61132468:C:A | R140S | 0.997 |
| 11:61132468:C:G | R140S | 0.997 |
| 11:61134101:A:G | L67P | 0.997 |
| 11:61134153:C:G | A50P | 0.997 |
| 11:61134185:C:G | R39P | 0.997 |
| 11:61132451:C:G | R146P | 0.996 |
| 11:61132458:G:C | H144D | 0.996 |
| 11:61134155:A:G | L49P | 0.996 |
| 11:61132533:C:G | A119P | 0.995 |
| 11:61134171:C:G | A44P | 0.995 |
| 11:61138795:A:G | L12P | 0.995 |
| 11:61132430:A:G | L153P | 0.994 |
| 11:61132480:A:C | F136L | 0.994 |
| 11:61132480:A:T | F136L | 0.994 |
| 11:61132482:A:G | F136L | 0.994 |
| 11:61134163:G:C | N46K | 0.994 |
| 11:61134163:G:T | N46K | 0.994 |
| 11:61134173:A:G | L43P | 0.994 |
| 11:61132457:T:G | H144P | 0.993 |
| 11:61132493:A:C | F132C | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000005211 (11:61153116 C>G,T), RS1000221270 (11:61146826 A>G), RS1000243183 (11:61137305 T>C), RS1000314390 (11:61137035 A>G), RS1000503490 (11:61130175 G>A), RS1000524699 (11:61152795 A>C,G), RS1000697099 (11:61135862 GC>G), RS1000793423 (11:61141475 G>C), RS1000971805 (11:61157581 C>T), RS1001131571 (11:61151410 T>C), RS1001351229 (11:61131317 CCT>C), RS1001385559 (11:61130968 T>TCGCC), RS1001417203 (11:61151702 C>T), RS1001676141 (11:61139583 G>A), RS1001832236 (11:61146757 C>T)
Disease associations
OMIM: gene MIM:610038 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005569_21 | Rheumatoid arthritis | 3.000000e-08 |
| GCST010726_46 | Periventricular white matter hyperintensities | 5.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005665 | white matter hyperintensity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation, increases expression | 2 |
| Tretinoin | affects cotreatment, increases expression | 2 |
| Cyclosporine | increases expression | 2 |
| GSK-J4 | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| mono-(2-ethylhexyl)phthalate | decreases methylation, increases abundance | 1 |
| sodium arsenite | affects cotreatment, increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Diethylhexyl Phthalate | increases abundance, decreases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.